Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion type Assertion NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_head.
- NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion description "[The results provide clinical implications that therapeutic targeting at the BRAF/MEK/MAP kinase pathway may be a good approach in restoring thyroid gene expression for effective radioiodine therapy for BRAF mutation-harboring PTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_provenance.
- NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion evidence source_evidence_literature NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_provenance.
- NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion SIO_000772 17317846 NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_provenance.
- NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion wasDerivedFrom befree-20140225 NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_provenance.
- NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_assertion wasGeneratedBy ECO_0000203 NP816061.RAIy8_DtHARjW7paM56repCszG49SZOJcgkxW9TyPnAeM130_provenance.